Leadership Team

Roy Jensen, MD Director, KU Cancer Center CEO, Masonic Cancer Alliance	Terance T. Tsue, MD, FACS Vice President and Physician-in-Chief, The University of Kansas Cancer Center
Shrikant Anant, PhD Associate Director, Basic Science	Joaquina Baranda, MD Director, Early-Phase Program, Clinical Research
Christie Befort, PhD Associate Director, Cancer Prevention and Control Co-leader, Cancer Control & Population Health	Teresa Christenson Associate Director Administration
Dan Dixon, PhD Co-Leader, Cancer Prevention and Survivorship	Gary Doolittle, MD Medical Director, Masonic Cancer Alliance
Edward Ellerbeck, MD, MPH Co-Leader, Cancer Control and Population Health	Alan Gamis, MD Co-Leader, Drug Discovery, Delivery and Experimental Therapeutics Program
Andrew Godwin, PhD Deputy Director, The University of Kansas Cancer Center Director, Biospecimen Repository	Jennifer Klemp, PhD Co-leader, Cancer Prevention and Survivorship Program
Linheng Li, PhD Co-leader, Cancer Biology	Tara Lin, MD Medical Director, Clinical Trials Office
Sally Maliski, PhD Associate Director, Equity	Matthew Mayo, PhD Associate Director, Shared Resources
Kristi Neufeld, PhD Co-Leader, Cancer Biology	Jeffrey Reene, MBA Chief Operating Officer
Weijing Sun, MD Division Director, Medical Oncology; Associate Director for Clinical Research	John Taylor, MD, MS Co-leader, Drug Discovery, Delivery and Experimental Therapeutics
Scott Weir, PharmD, PhD Associate Director, Translational Research; Director, Institute for Advancing Medical Innovation	Danny Welch, PhD Associate Director, Education